General
COVID-19 2nd Booster Dose Guidance 03-30-2022
Health Emergency Management - General
March 30, 2022
HAN Alert COVID-19 2nd Booster Dose Guidance
1915(c) Waiver Allocation and Transition Guide
Supports Waiver - General
March 30, 2022
1915(c) Waiver Allocation and Transition Guide
All 2020-2016 HAN Alerts
Health Emergency Management - General
March 28, 2022
All 2021 HAN Alerts
Registration Guide Dec 2016, Cipro Resistant Meningitidis - 08-06-2020, Remdesivir Update Guidance - 08-28 2020, COVID-19 Pre-Season - 09-11-2020, COVID-19 - 09-2020, COVID-19 - 01-16-2020, COVID-19 - 03-31-2020, COVID-19 -04-01-2020, COVID-19 - Directive Reporting Testing Data on Portal - 04-03-2020, COVID-19 - TB Testing Deferment - 04-44-2020, COVID-19 - 04-20-2020 , COVID-19 - 05-06-2020, COVID-19 - Menthol - 06-17-2020, COVID-19 - Antibody Testing - 07-02-2020, COVID-19 - NIH Summary - 07-28-2020, COVID-19 - Rapid Antigen Tests - 10-16-2020, COVID-19 - Crisis Staffing Tiers - 11-19-2020, COVID-19 - 12-03-2020, COVID-19 - Pfizer Vaccine Training Series For Clinicians, COVID-19 - 12-21-2020, COVID-19 - Phase 1 A - 12-21-2020 , COVID-19 - Releases Clinical Guidance Following VaST Technical Report - 06-25-2021, COVID-19 - 432 MIS-C Associated With COVID - 05-14-2020.
Medical Cannabis Program - Program Update 03/22/2022
Medical Cannabis Advisory Board - General
March 24, 2022
Medical Cannabis Program - Program Update 03/22/2022
All 2021 HAN Alerts ( Except December)
Health Emergency Management - General
March 23, 2022
All 2021 HAN Alerts ( Except December)
Wound Botulizm - 01-12-2021, COVID-19 Non-Hospital Therapeutics Admin Application - 01-21-2021, Wound Botulism - 01-21-2021, COVID-19 Pediatric Covid Testing - 02-01-2021, Advisory Requirements For TB Testing Of HCW Resumes - 04-01-2021, COVID-19 Vaccine Eligibility - 06-04-2021, COVID-19 Pause in J&J Distribution - 04-13-2021, COVID-19 Third Dose FOr Immunocompromised - 04-16-2021, NMMAT Pfizer Vaccine Recommendation 12 Years and Older - 05-13-2021, COVID-19 VaST Technical Report - 06-24-2021, Sodium Citate Lab Tube Shortage - 06-06-2021, COVID-19 Vaccine Data Improvement - 06-13-2021, COVID-19 Clinical Guidance Myocarditis Following mRNA Vaccination - 06-25-2021, RSV Surveillance - 07-22-2021, COVID-19 No Boosters Yet - 08-03-2021, COVID-19 Invermectin Toxicity - 09-10-2021.
December 2021 HAN Alerts
Health Emergency Management - General
March 21, 2022
December 2022 HAN Alerts
CDC 00438 - 12-17-2021, Shigella In Metro Homeless - 12-16-2021, COVID-19 Boosters for 16-17 - 12-09-2021, COVID-19 Evusheld - mAb - 12-08-2021, COVID-19 CDC 459 Varient Of Concern Identified - Omicron - 12-01-2021.
SW Communication Moratorium 03-08-2022
Supports Waiver - General
March 18, 2022
SW Communication Moratorium
MCAB Meeting Notice 03-22-2022
Medical Cannabis Advisory Board - General
March 16, 2022
MCAB Meeting Notice 03-22-2022
January 2022 HAN Alerts
Health Emergency Management - General
March 16, 2022
January 2022 HAN Alerts
Updated Guidance on Managing Healthcare Personnel with Infection or Exposure - 01-05-2022, CDC and FDA Update Indications for Pfizer-BioNTech COVID-19 Vaccine - 01-06-2022, Update on Omicron and COVID-19 Therapeutics - 01-07-2022, CDC and FDA Shorten Booster Interval for Moderna COVID-19 Vaccine - 01-10-2022, Public Health Order Enforcement to start 2/4/2022 of Up To Date Vaccination of Status - 01-14-2022, Therapeutics Update:Eligibility Criteria & Oral Antiviral & Monoclonal Antibody - 01-25-2022, Requirements on Electronic Death Certifications - 01-24-2022.
DDW Service Planning and Budgets for Adults: Clinical Review & Clinical/Service Criteria V6 (effective 11/1/2021)
Developmental Disabilities Waiver - General
March 16, 2022
DDW Service Planning and Budgets for Adults: Clinical Review & Clinical/Service Criteria
February 2022 HAN Alerts
Health Emergency Management - General
March 14, 2022
February 2022 HAN Alerts
Guidance for immunocompromised - 02-15-2022 , COVID Therapeutics - Quick Reference for Prescribers - 02-16-2022, COVID-19 Therapeutics Update: Patient Eligibility Criteria & New COVID-19 Therapeutic - 02-16-2022, COVID -19 Dealth Risk Increases as the Number of Comorbid Conditions Increases - 02-16-2022, COVID -19 Dealth Risk for Select Age Groups and Comorbid Conditions - 02-16-2022, Update for Providers regarding COVID-19 & Immunocompromised Patients - 02-22-2022, COVID-19 Therapeutics Update: Evusheld - 02-28-2022.
DDW Numbered Memo 2022-2
Developmental Disabilities Waiver - General
March 4, 2022
CESP or Acre Training Requirements Compliance Extension
DDW Numbered Memo 2022-4
Developmental Disabilities Waiver - General
March 4, 2022
Revisions to Comprehensive Risk Management Plan Document
DDW Numbered Memo 2022-5
Developmental Disabilities Waiver - General
March 4, 2022
Statewide Aspiration Risk List (SARL) transition to Smartsheet
Vaccine Purchase Act Provider Listing 2022
Immunization - General
February 28, 2022
This is a list of provider names.
DDW Numbered Memo 2022-3
Developmental Disabilities Waiver - General
February 28, 2022
DDW Standards Chapter 22.4: Annual Reports; Supports Waiver Standards
Current Advisory Council Members List
Opioid Safety - General
February 21, 2022
Current Advisory Council Members List
Naloxone Standing Order for Opioid Treatment Centers/Programs
Opioid Safety - General
February 16, 2022
Naloxone Standing Order for Opioid Treatment Centers/Programs
Notice of Minor, Nonsubstantive Correction 7.1.32
Health Improvement - General
February 9, 2022
Notice of Minor, Nonsubstantive Correction 7.1.32